Everett Cunningham - 25 Jun 2025 Form 4 Insider Report for ARVINAS, INC. (ARVN)

Reporting relationship: Director
Issuer ticker: ARVN
Reported as of: 25 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 27 Jun 2025, 21:08:47 UTC
Prior SEC filing: 07 Mar 2025
Next SEC filing: 08 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Jared Freedberg, as attorney-in-fact for Everett Cunningham

Key filing fact

Everett Cunningham filed Form 4 for ARVINAS, INC. (ARVN) on 27 Jun 2025.

Key facts

This page summarizes Everett Cunningham's Form 4 filing for ARVINAS, INC. (ARVN).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 27 Jun 2025, 21:08.

Change

Previous filing in this sequence was filed on 07 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001564777 Primary reporting owner

Cunningham Everett

Relationship: Director
Address: C/O ARVINAS, INC., 5 SCIENCE PARK, 395 WINCHESTER AVE., NEW HAVEN
Signature: /s/ Jared Freedberg, as attorney-in-fact for Everett Cunningham
Signature date: 27 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARVN transaction

Common Stock

Award

Transaction value: $0
Shares: +16,025
Change %: +160%
Price: $0.000000
Shares after: 26,045
Date: 25 Jun 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ARVN transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +23,105
Change %
Price: $0.000000
Shares after: 23,105
Date: 25 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 23,105
Exercise price: $7.80
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The restricted stock units (each, an "RSU") were granted by the Issuer on June 25, 2025 and each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement for no consideration. The RSUs shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.

Footnote F2

This option award was granted on June 25, 2025. The shares underlying the award shall vest in full on the earlier of June 25, 2026 or the first meeting of the board of directors of the Issuer held after the following annual meeting of stockholders, subject to the reporting person's continued service with the Issuer on the vesting date.